Skip to main content
LMRI
NASDAQ Technology

Lumexa Imaging Projects Strong Q4 Revenue of $261M, Issues 2026 Guidance

feedReported by Reuters
Sentiment info
Positive
Importance info
8
Price
$14.14
Mkt Cap
$1.337B
52W Low
$9.965
52W High
$19.45
Market data snapshot near publication time

summarizeSummary

Lumexa Imaging Holdings announced preliminary unaudited fourth-quarter 2025 revenues of at least $261 million, aligning with analyst expectations. The company expects full-year 2025 revenues of at least $1.016 billion, slightly below the $1.02 billion consensus. Furthermore, Lumexa provided 2026 financial guidance, projecting consolidated revenues between $1.045 billion and $1.097 billion, which brackets the analyst view of $1.07 billion. This initial release of financial performance and forward-looking guidance provides critical information for investors to assess the company's trajectory and valuation. Traders will be watching the upcoming earnings conference call for further details and management commentary.

At the time of this announcement, LMRI was trading at $14.14 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $9.97 to $19.45. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


show_chartPrice Chart

Share this article

Copied!

feed LMRI - Latest Insights

LMRI
Mar 30, 2026, 5:32 PM EDT
Filing Type: 10-K
Importance Score:
8
LMRI
Mar 26, 2026, 6:09 AM EDT
Filing Type: 8-K
Importance Score:
8
LMRI
Mar 26, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
LMRI
Mar 02, 2026, 9:12 AM EST
Source: Reuters
Importance Score:
8
LMRI
Mar 02, 2026, 6:14 AM EST
Filing Type: 8-K
Importance Score:
8